Circulating Betatrophin in Patients with Type 2 Diabetes: A Meta-Analysis

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Li, Sheyu ^a   Liu, Dan ^a   Li, Ling ^a   Li, Yun ^b   Li, Qianrui ^a   An, Zhenmei ^a   Sun, Xin ^a   Tian, Haoming ^a  

^a SICHUAN UNIVERSITY   (China)

^b Third Hospital of Chengdu   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BETATROPHIN; C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; LIPASIN PROTEIN, HUMAN; PEPTIDE HORMONE;

ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; BLOOD; COMPLICATION; INSULIN RESISTANCE; META ANALYSIS; OBESITY;

BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; OBESITY; PEPTIDE HORMONES;

EID: 84949968813     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/6194750     Document Type: Article

References (30)

1. R. Zhang, "Lipasin, a novel nutritionally-regulated liverenriched factor that regulates serum triglyceride levels," Biochemical and Biophysical Research Communications, vol. 424, no. 4, pp. 786-792, 2012.
2. G. Ren, J. Y. Kim, and C. M. Smas, "Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism," American Journal of Physiology-Endocrinology and Metabolism, vol. 303, no. 3, pp. E334-E351, 2012.
3. F. Quagliarini, Y. Wang, J. Kozlitina et al., "Atypical angiopoietin-like protein that regulates ANGPTL3," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 48, pp. 19751-19756, 2012.
4. Y. Wang, F. Quagliarini, È. Gusaroèa et al., "Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 40, pp. 16109-16114, 2013.
5. X.-Y. Dong, X.-W. Pang, S.-T. Yu et al., "Identification of genes differentially expressed in human hepatocellular carcinoma by a modified suppression subtractive hybridization method," International Journal of Cancer, vol. 112, no. 2, pp. 239-248, 2004.
6. Z. Fu, F. Yao, A. B. Abou-Samra, and R. Zhang, "Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family," Biochemical and Biophysical Research Communications, vol. 430, no. 3, pp. 1126-1131, 2013.
7. R. Zhang and A. B. Abou-Samra, "Emerging roles of Lipasin as a critical lipid regulator," Biochemical and Biophysical Research Communications, vol. 432, no. 3, pp. 401-405, 2013.
8. P. Yi, J.-S. Park, and D. A. Melton, "Betatrophin: a hormone that controls pancreatic beta cell proliferation," Cell, vol. 153, no. 4, pp. 747-758, 2013.
9. V. Gusarova, C. Alexa, E. Na et al., "ANGPTL8/betatrophin does not control pancreatic beta cell expansion," Cell, vol. 159, no. 3, pp. 691-696, 2014.
10. D. Espes, M. Martinell, and P. O. Carlsson, "Increased circulating betatrophin concentrations in patients with type 2 diabetes," International Journal of Endocrinology, vol. 2014, Article ID 323407, 6 pages, 2014.
11. Z. Fu, F. Berhane, A. Fite, B. Seyoum, A. B. Abou-Samra, and R. Zhang, "Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity," Scientific Reports, vol. 4, article 5013, 2014.
12. T. Ebert, S. Kralisch, A. Hoffmann et al., "Circulating angiopoietin-like protein 8 is independently associated with fasting plasma glucose and type 2 diabetes mellitus," The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 12, pp. E2510-E2517, 2014.
13. J. Gómez-Ambrosi, E. Pascual, V. Catalán et al., "Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes," The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 10, pp. E2004-E2009, 2014.
14. X. Chen, P. Lu, W. He et al., "Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance," The Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 1, pp. E96-E100, 2015.
15. H. Hu, W. Sun, S. Yu et al., "Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients," Diabetes Care, vol. 37, no. 10, pp. 2718-2722, 2014.
16. H. Yamada, T. Saito, A. Aoki et al., "Circulating betatrophin is elevated in patients with type 1 and type 2 diabetes," Endocrine Journal, vol. 62, no. 5, pp. 417-421, 2015.
17. R. Zhang and A. B. Abou-Samra, "A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy," Cardiovascular Diabetology, vol. 13, article 133, 2014.
18. G. A. Wells, B. Shea, D. O'Connell et al., "The Newcastle-Ottawa Scale(NOS) for assessing the quality of nonrandomised studies in meta-analyses," Ottawa Health Research Institute, http://www.ohri.ca/programs/clinical epidemiology/oxford.htm.
19. Z. Fu, A. B. Abou-Samra, and R. Zhang, "An explanation for recent discrepancies in levels of human circulating betatrophin," Diabetologia, vol. 57, no. 10, pp. 2232-2234, 2014.
20. A. Fenzl, B. K. Itariu, L. Kosi et al., "Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals," Diabetologia, vol. 57, no. 6, pp. 1204-1208, 2014.
21. D. Espes, J. Lau, and P.-O. Carlsson, "Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes," Diabetologia, vol. 57, no. 1, pp. 50-53, 2014.
22. K. Guo, J. Lu, H. Yu et al., "Serum betatrophin concentrations are significantly increased in overweight but not in obese or type 2 diabetic individuals," Obesity, vol. 23, no. 4, pp. 793-797, 2015.
23. Y. H. Tseng, Y. H. Yeh, W. J. Chen, and K. H. Lin, "Emerging regulation and function of betatrophin," International Journal of Molecular Sciences, vol. 15, no. 12, pp. 23640-23657, 2014.
24. Y. Jiao, J. Le Lay, M. Yu, A. Naji, and K. H. Kaestner, "Elevated mouse hepatic betatrophin expression does not increase human β-Cell replication in the transplant setting," Diabetes, vol. 63, no. 4, pp. 1283-1288, 2014.
25. K. H. Kaestner, "Betatrophin-promises fading and lessons learned," Cell Metabolism, vol. 20, no. 6, pp. 932-933, 2014.
26. Y. Zhang, R. Li, Y. Meng et al., "Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERKMAP kinase signaling," Diabetes, vol. 63, no. 2, pp. 514-525, 2014.
27. D. Espes, J. Lau, and P. O. Carlsson, "Increased levels of irisin in people with long-standing Type 1 diabetes," Diabetic Medicine, vol. 32, no. 9, pp. 1172-1176, 2015.
28. S. Tokumoto, Y. Hamamoto, K. Fujimoto et al., "Correlation of circulating betatrophin concentrations with insulin secretion capacity, evaluated by glucagon stimulation tests," Diabetic Medicine, vol. 32, no. 5, pp. 653-656, 2015.
29. S. Wu, H. Gao, Y. Ma, L. Fu, C. Zhang, and X. Luo, "Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance," Pediatric Diabetes, 2014.
30. J. Chen, S. Chen, P. Huang et al., "In vivo targeted delivery of ANGPTL8 gene for beta cell regeneration in rats," Diabetologia, vol. 58, no. 5, pp. 1036-1044, 2015.